Top Supplements Brands
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Supplements Brands
Supplements News
Procurement Decisions Become More Complex for NGS Sequencing Buyers
Friday, July 03, 2026
Selecting an NGS omics sequencing provider is becoming a more demanding process for many research organizations. While sequencing technologies continue to advance, buyers often find that choosing a service provider involves much more than comparing technical specifications and project costs. One reason is the increased scrutiny surrounding research spending. Funding organizations, internal review boards and program leaders frequently expect clear justification for sequencing-related investments. This can make purchasing decisions more complicated, particularly when multiple vendors appear capable of delivering similar services. The nature of omics research also contrib
Growing Use of Omics Sequencing Highlights Workflow Challenges
Friday, July 03, 2026
Interest in NGS omics sequencing continues to expand across research environments, yet adoption often exposes weaknesses in surrounding research workflows. Sequencing itself may be highly advanced, but many organizations discover that upstream preparation and downstream management require equal attention. Some of these issues emerge in the research process, even before samples reach the sequencing stage. Sample collection methods, storage practices and study design decisions can all influence project quality. Even when sequencing is performed successfully, problems introduced earlier in the workflow may affect the interpretation of results later in the study. When sele
NGS Omics Projects Place Greater Emphasis on Data Interpretation
Friday, July 03, 2026
Generating sequencing data is no longer the primary concern for many organizations using NGS omics technologies. Access to sequencing services has expanded significantly across genomics, transcriptomics and related research areas. The challenge increasingly lies in understanding the information produced and determining how it can be applied to biological research questions. This issue is becoming more visible as sequencing datasets continue to grow. Research teams can now generate large amounts of information within a relatively short period of time. However, turning those datasets into useful scientific findings often requires analytical expertise that is not always available w
Evaluating Precision, Reliability in Omics Sequencing Services
Tuesday, May 26, 2026
Advances in next-generation sequencing have expanded the scope of biological discovery, yet they have also increased pressure on research teams to select service providers that can deliver dependable data under varied and often unpredictable conditions. For executives responsible for sourcing omics sequencing services, the challenge is less about access to technology and more about ensuring that the output is scientifically meaningful, reproducible and aligned with specific research objectives. Laboratories today face constraints ranging from limited sample quality to compressed timelines, making service quality inseparable from project success. A consistent concern across life
Understanding the Risks and Benefits of Clinical Trials
Monday, December 30, 2024
Clinical trials pave the way for future breakthroughs and represent a partnership between science and humanity in the pursuit of better health. Fremont, CA: Clinical trials are vital in advancing healthcare and developing new treatments. Understanding clinical trials' purpose, process, and implications is crucial for making informed decisions. The knowledge empowers patients to evaluate the risks and benefits while contributing to the scientific community's quest for improved healthcare solutions. They follow a structured process with several phases, each with specific objectives. Phase trials assess safety and dosage in a small group of
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
Thursday, September 19, 2024
FREMONT, Calif-- Cytek Biosciences, Inc. (Nasdaq: CTKB) is set to elevate its presence at this year’s premier clinical industry events across the globe. Continuing its commitment to advancing cell analysis, Cytek will spotlight its Full Spectrum Profiling™ (FSP™) technology at the
